Researchers demonstrated that periplocymarin synchronously activated lethal apoptosis and protective autophagy in liver cancer, and the initiation of autophagy counteracted the inherent pro‑apoptotic capacity and impaired the anti‑cancer effects.
[International Journal Of Oncology]